Indeed, miRNA expression dysregulations have been described in patients affected by MS [31], with miR-155 miR-491 and miR-338 overexpressed in both patients and the EAE mouse model of MS, which also target AKR1C1 [27]. Here, AKR1C1 is linked to myeloid sarcoma.